An atlas of the unfamiliar within
Alien Peptides: strange things from inside us
A calf’s thymus, mitochondrial DNA, a fragment from stomach biology, a copy of gut-hormone signals: familiar origins for an atlas of unfamiliar chemistry.
Thymosin alpha-1: the interrupted story
A calf-thymus discovery, an immune brake and a later trial that changed the sepsis argument.
Follow the timeline →MOTS-c: a message takes the return journey
Mitochondrial instructions, a trip to the nucleus and a human blood study with an awkward twist.
Read the cellular dispatch →BPC-157: the repair dossier
Blood vessels grow in experimental models. The human repair story is still missing its decisive test.
Examine the repair claim →Tirzepatide: the signal that got measured
An engineered hormone mimic, weight changes in people and the costs that belong beside those results.
Look at the trial results →The name sent me inward
Alien Peptides sounds like a place for something from another world. Give me a place of origin before a list of benefits. Thymosin alpha-1 was isolated from calf thymus; MOTS-c is encoded in mitochondrial DNA, inside the small structures that help cells supply energy. BPC-157 is a synthetic fragment based on a protein in stomach fluid, while tirzepatide is a synthetic mimic of two gut-hormone signals. Familiar places, unfamiliar chemistry.
A peptide is a short chain of amino acids, the same building blocks found in proteins, but sharing that description does not give these four molecules a shared story. Each origin leads to a different argument about repair, immunity or ageing. I distrust the habit of treating a shared building material as a shared medical future.
The surprise is how much strange chemistry starts in ordinary anatomy. Finding a molecule there is one discovery; establishing what it can do in an illness is another.
Four entries, four different journeys
The 1977 thymus paper is an unusually tangible beginning: a gland, a purified peptide, its sequence worked out. The thymosin alpha-1 entry follows that beginning into an immune system with both an accelerator and a brake, then into a survival trial that interrupted the hopeful story.
With MOTS-c, the unexpected route runs from mitochondria to the nucleus. In experiments with human and mouse cells, a peptide encoded in mitochondria reached the nucleus under metabolic stress and helped regulate gene activity. That journey has a definite start and destination. “Extra energy” is a much vaguer place.
Stomach-fluid biology gives BPC-157 a very different starting point. The blood-vessel experiments are specific and interesting; the human evidence is much smaller than the reputation. Tirzepatide travelled further: large human trials actually compared weight changes. Here, it is the case where an engineered signal made it well beyond an intriguing laboratory result.
The result I could not leave out
The most consequential landmark here is a disappointing result. The largest thymosin alpha-1 sepsis trial, TESTS, with 1,106 adults, did not establish better survival. That matters even though the molecule’s immune biology remains interesting. For me, an interesting origin cannot outweigh a survival trial.
The four-entry comparison puts those different kinds of finding beside each other. It is a map of what was studied, rather than a contest to pick a favourite molecule. The original reports are in the reading list.
The blank spaces belong on the map
Tirzepatide has FDA-approved prescription uses. Thymosin alpha-1 has no US drug approval, despite the international medical use described in a review. MOTS-c and BPC-157 lack FDA approval for treating people; the BPC-157 review describes an investigational compound with very limited human data. A study also cannot establish the identity or sterility of a separate research product.
Mitochondrial origins and experimental repair give the atlas entries whose human outcomes remain unknown. Accounts of feeling better are anecdotal accounts, not clinical evidence. Curiosity is reason enough to visit those blank spaces; it is no basis for a treatment instruction.